E-LIB Suche - Ergebnisse für: Thilakarathne, Pushpike

1

Comparing Efficacy of Guselkumab versus Ustekinumab in Pati..:

Thilakarathne, Pushpike ; Schubert, Agata ; Peterson, Steve...
Rheumatology and Therapy. 11 (2024) 2 - p. 457-474 , 2024

Link: https://doi.org/10.1007/..

2

P979: PATIENT-REPORTED OUTCOMES FOR TECLISTAMAB VERSUS REAL..:

Moreau, Philippe ; van de Donk, Niels W.C.J. ; Delforge, Michel...
HemaSphere. 7 (2023) S3 - p. e690758f , 2023

Link: https://doi.org/10.1097/..

3

Matching-adjusted indirect comparison (MAIC) results confir..:

Signorovitch, James ; Diels, Joris ; Van Sanden, Suzy...
Journal of Dermatological Treatment. 34 (2023) 1 - p. , 2023

Link: https://doi.org/10.1080/..

4

P922: ADJUSTED COMPARISONS OF CILTACABTAGENE AUTOLEUCEL WIT..:

Mateos, Maria-Victoria ; Weisel, Katja ; Martin, Tom...
HemaSphere. 7 (2023) S3 - p. e641482c , 2023

Link: https://doi.org/10.1097/..

5

Clinical Burden of Respiratory Syncytial Virus in Hospitali..:

Hartmann, Katrin ; Liese, Johannes G ; Kemmling, Daniel...
The Journal of Infectious Diseases. 226 (2022) 3 - p. 386-395 , 2022

Link: https://doi.org/10.1093/..

6

P-259: Ciltacabtagene autoleucel (cilta-cel) versus real wo..:

Mateos, María-Victoria ; Weisel, Katja ; Vincent, Laure...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S179 , 2022

Link: https://doi.org/10.1016/..

7

Adjusted comparison of outcomes between patients from CARTI..:

Mateos, Maria-Victoria ; Weisel, Katja ; Martin, Thomas...
Haematologica. 108 (2022) 8 - p. 2192-2204 , 2022

Link: https://doi.org/10.3324/..

8

Cost-effectiveness analysis of bortezomib in combination wi..:

van Keep, Marjolijn ; Gairy, Kerry ; Seshagiri, Divyagiri..
BMC Cancer. 16 (2016) 1 - p. , 2016

Link: https://doi.org/10.1186/..

9

Converging or Crossing Curves: Untie the Gordian Knot or Cu..:

Tomeczkowski, Jörg ; Lange, Ansgar ; Güntert, Andreas...
Advances in Therapy. 32 (2015) 9 - p. 854-862 , 2015

Link: https://doi.org/10.1007/..

10

The use of semiparametric mixed models to analyze PamChip® ..:

Thilakarathne, Pushpike J. ; Clement, Lieven ; Lin, Dan...
Bioinformatics. 27 (2011) 20 - p. 2859-2865 , 2011

Link: https://doi.org/10.1093/..

11

Modeling the asymmetric evolution of a mouse and rat-specif..:

Lehnert, Stefan ; Kapitonov, Vladimir ; Thilakarathne, Pushpike J.
BMC Genomics. 12 (2011) 1 - p. , 2011

Link: https://doi.org/10.1186/..

12

Evidence for Co-Evolution between Human MicroRNAs and Alu-R..:

Lehnert, Stefan ; Van Loo, Peter ; Thilakarathne, Pushpike J....
PLoS ONE. 4 (2009) 2 - p. e4456 , 2009

Link: https://doi.org/10.1371/..

13

A Nonlinear Mixed-Effects Model for Estimating Calibration ..:

Thilakarathne, Pushpike J ; Verbeke, Geert ; Engelen, Kristof.
Statistical Applications in Genetics and Molecular Biology. 8 (2009) 1 - p. 1-25 , 2009

Link: https://doi.org/10.2202/..

14

P979: PATIENT-REPORTED OUTCOMES FOR TECLISTAMAB VERSUS REAL..:

Moreau, Philippe ; van de Donk, Niels W.C.J ; Delforge, Michel...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431245/. , 2023

Link: http://www.ncbi.nlm.nih...

15

P922: ADJUSTED COMPARISONS OF CILTACABTAGENE AUTOLEUCEL WIT..:

Mateos, Maria-Victoria ; Weisel, Katja ; Martin, Tom...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431099/. , 2023

Link: http://www.ncbi.nlm.nih...